Upsher-Smith Laboratories announced that it has extended its line of Haloperidol Tablets, USP and is now offering unit dose packaging in 1 mg, 5 mg, and 10 mg strengths.
The new packaging aims to expand supply options for dispensing pharmacies that utilize unit-dose packaged products. Upsher-Smith's Haloperidol Tablets are also available in bottles of 100 tablets in 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg strengths. Haloperidol Tablets are a generic version of the brand product, Haldol® Tablets*.
The haloperidol unit-dose tablet market had U.S. sales of approximately $9 million for the 12 months ending July 2022 according to IQVIA.